Journal of Pharma and Drug Innovation

Frequency : Annual (One issue per year)
Editorial & Review Timeline
3 - 4 Days Initial Quality Review
20 Days Peer Evaluation Summary
30 - 45 Days Complete Editorial Processing Time
Gut Dysbiosis: A Key Player in Metabolic health Management
Review Article - Volume: 1, Issue: 1, 2026 (June)

Krishna Chandra Panda1*, B.V.V Ravi Kumar1*, Jammula Sruti1*, Digambar Bisoi1*Laxmidhar Sahoo1*

1Roland Institute of Pharmaceutical Sciences, Khodasingi, Berhampur, Pin-760010, Odisha, India

*Correspondence to: Krishna Chandra Panda, Roland Institute of Pharmaceutical Sciences, Khodasingi, Berhampur, Pin-760010, Odisha, India; Email:

Received: December 01, 2025; Manuscript No: JPDI-25-1802; Editor Assigned: December 19, 2025; PreQc No: JPDI-25-1802 (PQ); Reviewed: January 18, 2026; Revised: May 09, 2026; Manuscript No: JPDI-25-1802 (R); Published: June 05, 2026

ABSTRACT

Gut dysbiosis, an imbalance in the microbial community of the intestines, has emerged as a significant contributor to metabolic syndrome, a cluster of conditions including obesity, insulin resistance, high blood pressure, and abnormal cholesterol levels. Recent studies indicate that gut dysbiosis can lead to increased inflammation, altered metabolism, and disruptions in the regulation of glucose and lipid levels, thereby promoting the development of metabolic syndrome. Intervention strategies to correct gut dysbiosis and mitigate its impact on metabolic syndrome are gaining attention. Probiotics, prebiotics, dietary changes, and fecal microbiota transplantation (FMT) are among the methods being explored. Probiotics, beneficial bacteria that can be consumed through supplements or fermented foods, help restore a healthy gut microbiome balance. Prebiotics, dietary fibers that feed beneficial gut bacteria, also play a crucial role in maintaining gut health. Additionally, adopting a diet rich in fruits, vegetables, whole grains, and lean proteins can support a healthy microbiome. FMT, a procedure where fecal matter from a healthy donor is transplanted into the gut of a person with dysbiosis, shows promise in restoring microbial balance and improving metabolic outcomes. If it is checked the initial level of Gut dysbiosis and major causes the metabolic syndrome can be prevented. Majority of all life style diseases like diabetes, cardiovascular diseases, Histamine intolerance, thyroid diseases and autoimmune diseases are due to Gut dysbiosis. So, if it is corrected metabolic syndrome may be prevented in the initial stages. These interventions, by targeting gut health, offer potential pathways to alleviate and prevent metabolic syndrome, highlighting the crucial link between gut microbiota and overall metabolic health and personalized medicine.

Keywords: Gut dysbiosis, metabolic syndrome, probiotics, prebiotics, dietary changes, fecal microbiota transplantation (FMT).


Citation: Panda KC, Kumar B.V.V R, Jammula S, Bisoi D, Sahoo L (2026). Gut Dysbiosis: A Key Player in Metabolic health Management. J. Pharma Drug Innov. Vol.1 Iss.1, June (2026), pp:9-19.
Copyright: © 2026 Krishna Chandra Panda, B.V.V Ravi Kumar, Jammula Sruti, Digambar Bisoi, Laxmidhar Sahoo. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.